According to EQL Pharma AB latest financial reports the total debt is $285.55K, an decrease of -74.39% to 2022. At the end of 2022 company had $1.11M total debt. This figure represents the debts and financial obligations that EQL Pharma AB combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $285.55K | -74.39% |
2022 | $1.11M | -34.41% |
2021 | $1.70M | Infinity% |
2020 | $0 | - |